STOCK TITAN

Korsana Biosciences: Wellington reports 5.72% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Korsana Biosciences, Inc. (KRSA) common stock is the subject of a Schedule 13G in which Wellington Management Group LLP, Wellington Group Holdings LLP, Wellington Investment Advisors Holdings LLP and Wellington Management Company LLP each report beneficial ownership of 2,601,096 shares, equal to 5.72% of the class. Each reports shared voting and dispositive power over 2,601,096 shares and zero sole voting or dispositive power. The shares are owned of record by clients of Wellington investment advisers.

Beneficial ownership 2,601,096 shares Reported by each of four reporting entities
Percentage of class 5.72% Reported in the ownership disclosure
beneficially owned regulatory
"2,601,096 shares beneficially owned by each reporting person"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared voting power regulatory
"Shared voting power of 2,601,096 shares"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power regulatory
"Shared dispositive power of 2,601,096 shares"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many KRSA shares did Wellington report owning?

Four Wellington entities each reported beneficial ownership of 2,601,096 KRSA common shares, representing 5.72% of the class. Each reported shared voting and dispositive power over 2,601,096 shares.

Who holds the KRSA shares reported by Wellington?

The shares are owned of record by clients of the Wellington Investment Advisers. Wellington listed Wellington Biomedical Innovation Master Investors (Cayman) II L.P. as an exception to its statement that no client is known to have rights to dividends or sale proceeds involving more than 5% of the class.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





23255M303

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Wellington Management Group LLP
Signature:Matthew Revell
Name/Title:Compliance Manager
Date:11/16/2026
Wellington Group Holdings LLP
Signature:Matthew Revell
Name/Title:Compliance Manager
Date:11/16/2026
Wellington Investment Advisors Holdings LLP
Signature:Matthew Revell
Name/Title:Compliance Manager
Date:11/16/2026
Wellington Management Company LLP
Signature:Matthew Revell
Name/Title:Compliance Manager
Date:11/16/2026

Keep reading